Tigermed

Tigermed

制药业

Hangzhou,Zhejiang 48,356 位关注者

Excellence. In every trial. For every patient.

关于我们

Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.

网站
http://www.tigermedgrp.com
所属行业
制药业
规模
5,001-10,000 人
总部
Hangzhou,Zhejiang
类型
上市公司
创立
2004
领域
BE study Generic Drugs Quality Consistency Evaluation、Preclinical/CMC/Bioanalytical、Clinical related services、Regulatory Affairs、Clinical trial---Phase I to IV & NIS和MART&Oversea clinical service

地点

  • 主要

    No.19 Jugong Road, Binjiang District

    F18, Building A – Shengda Science Park

    CN,Zhejiang,Hangzhou,310053

    获取路线
  • Changning District, Shanghai,P.R.China

    Fl.16,999 West Zhongshan Road,

    CN,Shanghai,Shanghai,200051

    获取路线
  • No.20 Chaoyangmen Outer Street,Chaoyang District, Beijing,P.R.China

    Room 808,Union Mansion

    CN,Beijing,Beijing,100020

    获取路线

Tigermed员工

动态

  • 查看Tigermed的公司主页,图片

    48,356 位关注者

    At Tigermed, we’re here to help clinical trial sponsors who are looking to take their trials international, who want to maximize their budget and streamline trial execution, who care deeply about the people actively participating in their trials. A decentralized trial is often the best fit for sponsors with these goals in mind. This trial design benefits everyone involved—it’s cost-effective, lowers the participation burden, and, with the right partner, can take trial efficiency to a new level. We’ve executed over 200 clinical trials that incorporate decentralized elements; our clients enjoy an average 30% cost reduction with 40% improved efficiency. As clinical trial designs become increasingly advanced and more complex, trial sponsors benefit most from working with an experienced thought partner to optimize their multi-national trial. Navigating decentralized trial logistics within a worldwide regulatory landscape poses an incredible challenge. Sponsors will need perspective into the intricacies of each region’s rules for decentralized trials. Read the full Blog at https://lnkd.in/gFqpEauc #DCT #clinical #trials #design #execution

    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    48,356 位关注者

    As GLP-1s continue to grow in popularity and become the future of #weight management, what new drugs are in the pipeline? Do they pose more benefits than risks? And how will they be used in the future? Tigermed team hosted a #symposium on July 18, 2024, in Zhangjiang, Shanghai on the topic of #GLP-1, exploring important #considerations and #strategies to support this rapidly changing pipeline of drugs from early phase, clinical applications, and the market's competitive landscape. Warmly welcoming more industry experts and peers to dive into the GLP-1 market and engage in meaningful discussions with Tigermed about combatting #obesity with the associated challenges and unknown long-term #effects.

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    48,356 位关注者

    Since our inception in 2004, Tigermed has been a trusted clinical research organization that provides full R&D services for the global biopharmaceutical and medical device industries. For 20 years, we have been accelerating the launch of innovative healthcare products with our quality, solutions, teams, experience, and expertise, to advance human health. Watching our new corporate video to learn more about Tigermed: https://lnkd.in/gY7QtUHX #tigermed #clinicaltrials #cro #clinicalresearch #healthcare

  • 查看Tigermed的公司主页,图片

    48,356 位关注者

    New page exploration in action with #Tigermed Tigermed fully integrated imaging evaluation services can provide comprehensive advice from early-stage development to Phase IV endpoints to improve critical decision-making considerations. Working with Tigermed’s #medical #imaging team benefits you with leading industrial experts' analysis and regulatory insight that will add value to your clinical development and management. We focus on providing medical imaging #CRO services and take the tenet of ‘Specialty, Dedication, Integrity’ to offer the best quality services for sponsors with high-speed feedback, reasonable prices and high-efficiency #execution. Learn more about Tigermed's capabilities and connect for a conversation at https://lnkd.in/gMHqgHqS

    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    48,356 位关注者

    Dive into the heart of #Tigermed's #brand #culture with our employees' stories. In this edition, we explore the brand pillar of #Quality, reaffirming our commitment to innovative service and global health.   We are pleased to invite Xixi Cheng to share her experience on Quality First is not only a slogan but also a working method and code of conduct. "I believe that ‘Quality’ is one of the most important principles in clinical trials. We always prioritize quality and ensure that our projects are completed to high standards through various methods such as regular SOP training and sharing CAPA cases. There is a case in the industry where a clinical trial was halted due to the sponsor's excessive focus on enrollment speed, leading to significant protocol deviations. This incident left a deep impression on me, reminding us that while we might ensure enrollment efficiency, we must not overlook the quality of the trial. Any compromise on quality may have adverse effects on the eventual market approval of the product. This case also made me realize deeply that Tigermed's commitment to ‘Quality’ lies in the rigor and professionalism throughout the process. We also adhere to this guiding principle to provide our clients with higher quality services."

    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    48,356 位关注者

    New page exploration in action with #Tigermed #Vaccine research is unique in its ability to have a widespread impact on global health. Now more than ever, vaccine development requires a more innovative and efficient approach. Our vaccine service scope covers vaccine clinical #design, #monitoring, data #statistics and biological #testing, we work closely with you to develop personalized roadmaps for your vaccine study and aim to maximize efficiency, anticipate challenges, and mitigate risk. Learn more about Tigermed's capabilities and connect for a conversation at https://lnkd.in/gm_Wkqir

    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    48,356 位关注者

    What an incredible week at #DIA 2024! From June 16th to 20th, Tigermed was immersed in an environment brimming with #innovation, #collaboration, and #forward-thinking discussions, presenting our pioneering solutions and demonstrating our unwavering commitment to excellence in clinical trials.   A heartfelt thank you to everyone who visited our booth. Stay connected with Tigermed for more exciting updates and developments as we continue to shape the future of #healthcare together!

    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    48,356 位关注者

    Dive into the heart of #Tigermed's #brand #culture with our employees' stories. In this edition, we explore the brand pillar of #Quality, reaffirming our commitment to innovative service and global health.   We are pleased to invite Katie Ponce to share her experience on Quality First is not only a slogan but also a working method and code of conduct. "I joined the Tigermed in early March and attended the team's first meeting. Colleagues emphasized the importance of choosing appropriate methods in our work and shared the viewpoint that 'even if the statistical methods we choose cannot prove the success of the research product, these methods must be of high quality.' Therefore, I believe that ‘Quality’ not only means the success of the trial, but also ensures the reliability, rigor, and interpretability of the methods and results. Only high-quality work can produce high-quality results, and I am delighted to be part of the biostatistics team. Here, I see the team improving the quality of statistical work through various means, which fills me with confidence in focusing on research work related to oncology compounds and contributing to the biostatistics work in clinical trials."

    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    48,356 位关注者

    We are thrilled to be heading back to the beautiful city of San Diego for #DIA2024!   Each year DIA brings together professionals across all sectors of the life science community, with a common goal and passion for improving health outcomes for patients across the globe. We are excited to have the opportunity to reconnect with friends, colleagues and partners as well as to showcase what Tigermed is doing to enhance health and drive medical innovation for all!   Whether you’re heading to DIA as well or just in the San Diego area, let us know or connect with Cooper Anderson at Tigermed’s booth #2021.

    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    48,356 位关注者

    As the largest and most comprehensive biotech event, #BIO #International #Convention brings together over 18,500 industry leaders. Join Tigermed at the SWISS BIOTECH Pavilion, Booth #2111, from June 3-6. We're here to connect with industry leaders, innovators, and professionals from all over the world, and excited to explore potential collaborations and discover how we can work together to advance the future of #biotechnology

    • 该图片无替代文字

相似主页

融资

Tigermed 共 2 轮

上一轮

未知

US$2,000,000.00

Crunchbase 上查看更多信息